Requiring fasting prior to lab tests may endanger some patients with diabetes by placing them at risk for hypoglycemia, new research indicates. Findings from surveys of over 350 patients were recently ...
LONDON, Dec. 1, 2021 /PRNewswire/ -- LumiraDx (Nasdaq: LMDX) announced today that the intended use for its Food and Drug Administration (FDA) Emergency Use Authorization (EUA) SARS-CoV-2 RNA STAR ...
LONDON, June 8, 2022 /PRNewswire/ -- LumiraDx Limited (Nasdaq: LMDX) today announced that it has achieved CE Mark for two new Fast Lab Solutions molecular tests, including Dual-Target SARS-CoV-2 STAR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results